Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 3027Generated: October 25, 2026

Isobutyric anhydride → methyl(11R,12S,13E,15S,17R)-9-isobutyryloxy-11,15-bis(tert-butyldimethylsiloxy)-17,20-dimethyl-7-thiaprosta-8,13-dienoate

https://huagongshe.com/reaction/3027

Reaction equation

Participants

RoleNameHCIDCharge
ReactantIsobutyric anhydrideHCID 7346—
Reactant(1E,3S,5R)-1-iodo-3-(tert-butyldimethylsiloxy)-5-methyl-1-noneneHCID 15689554—
Reactant(4R)-tert-butyldimethylsiloxy-2-(5-methoxycarbonylpentylthio)-2-cyclopenten-1-oneHCID 131720587—
ReactantHCID 178418306HCID 178418306—
ReactantC6H9CuHCID 178418419—
SolventHexamethylphosphorous triamideHCID 15355—
Productmethyl(11R,12S,13E,15S,17R)-9-isobutyryloxy-11,15-bis(tert-butyldimethylsiloxy)-17,20-dimethyl-7-thiaprosta-8,13-dienoateHCID 2288379865%

Reaction Steps

Using as the materials and reagents (1E,3S,5R)-1-iodo-3-(tert-butyldimethylsiloxy)-5-methyl-1-nonene (476 mg, 1.2 mmol), tert-butyllithium (1.54 mol/l, 1.56 ml, 2.4 mmol), 174 mg of 1-hexynylcopper, hexamethylphosphorous triamide (436 μl), (4R)-tert-butyldimethylsiloxy-2-(5-methoxycarbonylpentylthio)-2-cyclopenten-1-one (373 mg, 1 mmol), and isobutyric anhydride (448 μl), the same procedure was performed as in Example 1 to obtain methyl(11R,12S,13E,15S,17R)-9-isobutyryloxy-11,15-bis(tert-butyldimethylsiloxy)-17,20-dimethyl-7-thiaprosta-8,13-dienoate (466 mg, 65%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05731452
Source datasetuspto-grants-1998_03
ORD IDord-8f870745fc5f496588a513ddc86e1f2b
Source noteuspto-grants-1998_03